Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Terason Partners with DiA Imaging Analysis to Bring Superior AI Cardiac Solutions to Point-Of-Care Ultrasound

DiA’s AI-Based Automated Cardiac Analysis Solutions Integrated in Terason’s Portable Ultrasound Devices

Terason, a leading global ultrasound imaging company based in Burlington, Mass., has partnered with DiA Imaging Analysis, a leading provider of Artificial Intelligence (AI)-based solutions for ultrasound analysis, to provide its cardiac solutions on Terason’s point-of-care ultrasound devices.

The partnership fills a market need for more accurate and objective image analysis for clinicians in hospitals and outpatient settings, that commonly analyze ultrasound images visually.

DiA’s flagship, FDA cleared and CE marked cardiac solution, LVivo Toolbox, leverages its pattern recognition, machine learning and deep learning-based technology to identify cardiac functions and abnormalities. LVivo’s AI-based algorithms generate fast, quantitative and objective results that support clinicians’ decision-making process and reduce the subjectivity associated with cardiac ultrasound analysis.

Read More: Nordic Enterprises Look to SAP S/4HANA for Finance and Supply Chain Management

Related Posts
1 of 19,825

“Left ventricle analysis represents the most frequent indication for an echo study and is pivotal for patient evaluation, management, and as an indicator for treatment initiation,” says Dr. Alice Chiang, Terason’s CEO and founder and industry pioneer.  “We always strive to offer users the most innovative solutions.  By joining with DiA, we will empower users with our best-in-class devices together with DiA’s most powerful automated algorithms, that provide superior solutions for managing patients with heart failure or cardiovascular disease.”

Since 2000, Terason has produced thousands of portable ultrasound systems, and has evolved to become a market leader in ultrasound-guided venous intervention. Its state-of-the-art ultrasound devices help clinicians to identify and treat a wide range of pathologies that can improve patient management.

Read More: How Has Deep Learning Impacted the Translation Industry?

Terason systems are routinely used in the fields of cardiology, vascular surgery, interventional radiology, endocrinology, nephrology, musculoskeletal (MSK), and breast surgery.  In addition, Terason is the first company to turn a laptop into an ultrasound machine.

“DiA and Terason have many shared values, and I am pleased that we have joined forces,” said Hila Goldman-Aslan, DiA’s CEO and Co-Founder. “The point-of-care ultrasound market is evolving quickly, and AI is driving this market. Partnering with Terason is another step toward accomplishing DiA’s vision to make ultrasound analysis smarter and accessible to all.”

Read More: $200 Million Investment into Big Data Analytics-Driven Cyber Defense Platform

Leave A Reply

Your email address will not be published.